Our Satellite Symposium was held during ECR 2022, on Thursday, March 3rd 2022 , and broadcasted LIVE through ESR Connect, the virtual learning platform of the European Society of Radiology.
Streamed live around the world from the ECR Studio in Vienna, the Canon Medical satellite symposium focuses on Outcomes driven innovation in Stroke. Speakers for this event are: Mahtab Zamani (Norway), Anton Meijer (Netherlands), Josep Puig (Spain) and Adnan Siddiqui (USA).
Background information:
Globally, stroke is a leading cause of mortality and disability with the World Stroke Organization reporting an annual mortality rate of 5 and a half million people*. Additionally, up to 50% of survivors have chronic disability posing a major public health problem and substantial economic burden. Identifying who is at risk for stroke, how to make the best decisions and perform complex procedures under such time pressure, all will be covered in this symposium session. Join our panel of experts to learn how guidelines updates and revised recommendations translate into clinical practice.
* Source: [ Ссылка ]
Why should you watch it
- Understand the diagnostic relevance of detecting neovascularization in unstable plaques by the use of SMI.
- See benefits of a wide CT detector and Bayesian brain CT perfusion.
- Understand the relevance of DTI as an early predictor of motor outcome in stroke patients.
- Get practical tips on stroke treatment from the clinical examples discussed to increase your diagnostic and treatment possibilities.
Program
* Detection of neovascularization with advanced ultrasound method (SMI) without using contrast material - Dr. Mahtab Zamani
* State-of-the-art brain CT perfusion in acute ischemic stroke – Dr. Anton Meijer
* Diffusion tensor imaging as a biomarker for stroke patients – Dr. Josep Puig
* Higher Definition, Easier Procedure, Better Outcomes – Prof. Adnan Siddiqui
For more information, please visit our website: [ Ссылка ]
Channel link: [ Ссылка ]
Website link: [ Ссылка ]
Connect with us at:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Linkedin: [ Ссылка ]
